Protective Role of the Portocaval Shunt in Liver Transplantation

2020 ◽  
Vol 52 (5) ◽  
pp. 1455-1458
Author(s):  
Laura Tortolero ◽  
Javier Nuño ◽  
Adolfo Buenadicha ◽  
Luis Gajate ◽  
Ana Serrano ◽  
...  
2001 ◽  
Vol 25 (3) ◽  
pp. 142-147 ◽  
Author(s):  
David A. Geller ◽  
Stanley H. Chia ◽  
Yoshihito Takahashi ◽  
Gautam P. Yagnik ◽  
George Tsoulfas ◽  
...  

2016 ◽  
Vol 22 (7) ◽  
pp. 968-978 ◽  
Author(s):  
Zhi-Bin Zhang ◽  
Wei Gao ◽  
Yuan Shi ◽  
Lei Liu ◽  
Ning Ma ◽  
...  

2020 ◽  
Vol 318 (3) ◽  
pp. G531-G541 ◽  
Author(s):  
So Yeon Kim ◽  
Kang Ho Kim ◽  
Jan M. Schilling ◽  
Joseph Leem ◽  
Mehul Dhanani ◽  
...  

Cirrhotic cardiomyopathy is a clinical syndrome in patients with liver cirrhosis characterized by blunted cardiac contractile responses to stress and/or heart rate-corrected QT (QTc) interval prolongation. Caveolin-3 (Cav-3) plays a critical role in cardiac protection and is an emerging therapeutic target for heart disease. We investigated the protective role of cardiac-specific overexpression (OE) of Cav-3 in cirrhotic cardiomyopathy. Biliary fibrosis was induced in male Cav-3 OE mice and transgene negative (TGneg) littermates by feeding a diet containing 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC; 0.1%) for 3 wk. Liver pathology and blood chemistries were assessed, and stress echocardiography, telemetry, and isolated heart perfusion studies to assess adrenergic responsiveness were performed. Cav-3 OE mice showed a similar degree of hyperdynamic contractility, pulmonary hypertension, and QTc interval prolongation as TGneg mice after 3 wk of DDC diet. Blunted systolic responses were shown in both DDC-fed Cav-3 OE and TGneg hearts after in vivo isoproterenol challenge. However, QTc interval prolongation after in vivo isoproterenol challenge was significantly less in DDC-fed Cav-3 OE hearts compared with DDC-fed TGneg hearts. In ex vivo perfused hearts, where circulatory factors are absent, isoproterenol challenge showed hearts from DDC-fed Cav-3 OE mice had better cardiac contractility and relaxation compared with DDC-fed TGneg hearts. Although Cav-3 OE in the heart did not prevent cardiac alterations in DDC-induced biliary fibrosis, cardiac expression of Cav-3 reduced QTc interval prolongation after adrenergic stimulation in cirrhosis. NEW & NOTEWORTHY Prevalence of cirrhotic cardiomyopathy is up to 50% in cirrhotic patients, and liver transplantation is the only treatment. However, cirrhotic cardiomyopathy is associated with perioperative morbidity and mortality after liver transplantation; therefore, management of cirrhotic cardiomyopathy is crucial for successful liver transplantation. This study shows cardiac myocyte specific overexpression of caveolin-3 (Cav-3) provides better cardiac contractile responses and less corrected QT prolongation during adrenergic stress in a cirrhotic cardiomyopathy model, suggesting beneficial effects of Cav-3 expression in cirrhotic cardiomyopathy.


2019 ◽  
Vol 2019 ◽  
pp. 1-11
Author(s):  
Peibiao Lv ◽  
Tufeng Chen ◽  
Peibin Liu ◽  
Lei Zheng ◽  
Jingling Tian ◽  
...  

Patients with orthotopic liver transplantation (OLT) frequently develop acute gut injury (AGI), and dexmedetomidine (Dex) has been reported to exert a protective effect against AGI. We investigated whether Dex protects against AGI through antioxidative stress effects by the Nrf2/HO-1 antioxidative signaling pathway. Rats were randomly allocated into a sham group and six orthotopic autologous liver transplantation (OALT) groups receiving different doses of Dex together with/without α2-adrenergic receptor (AR) blockers. Intestinal tissues were collected to visualize the barrier damage and to measure the indexes of oxidative stress. For in vitro studies, rat intestinal recess epithelial cells (IEC-6) underwent hypoxia/reoxygenation (H/R), and the protective role of Dex was evaluated after α2A-AR siRNA silencing. OALT resulted in increased oxidative stress, significant intestinal injury, and barrier dysfunction. Dex attenuated OALT-induced oxidative stress and intestinal injury, which was abolished by the pretreatment with the nonspecific α2A-AR siRNA blocker atipamezole and the specific α2A-AR siRNA blocker BRL-44408, but not by the specific 2B/C-AR siRNA blocker ARC239. Silencing of α2A-AR siRNA also attenuated the protective role of Dex on alleviating oxidative stress in IEC-6 cells subjected to H/R. Dex exerted its protective effects by activating Nrf2/HO-1 antioxidative signaling. Collectively, Dex attenuates OALT-induced AGI via α2A-AR-dependent suppression of oxidative stress, which might be a novel potential therapeutic target for OALT-induced AGI.


2006 ◽  
Vol 5 (7) ◽  
pp. 1300-1313 ◽  
Author(s):  
Anouk Emadali ◽  
Béatrice Muscatelli-Groux ◽  
Frédéric Delom ◽  
Sarah Jenna ◽  
Daniel Boismenu ◽  
...  

2010 ◽  
Vol 53 (1) ◽  
pp. 73-83 ◽  
Author(s):  
Jindao Wu ◽  
Qiyun Tang ◽  
Jian Shen ◽  
Aihua Yao ◽  
Fuqiang Wang ◽  
...  

2017 ◽  
Vol 23 (4) ◽  
pp. 498-509 ◽  
Author(s):  
Delia D'Avola ◽  
Valentín Cuervas-Mons ◽  
Josep Martí ◽  
Jorge Ortiz de Urbina ◽  
Laura Lladó ◽  
...  

2020 ◽  
Vol 134 (1) ◽  
pp. 71-72
Author(s):  
Naseer Ahmed ◽  
Masooma Naseem ◽  
Javeria Farooq

Abstract Recently, we have read with great interest the article published by Ibarrola et al. (Clin. Sci. (Lond.) (2018) 132, 1471–1485), which used proteomics and immunodetection methods to show that Galectin-3 (Gal-3) down-regulated the antioxidant peroxiredoxin-4 (Prx-4) in cardiac fibroblasts. Authors concluded that ‘antioxidant activity of Prx-4 had been identified as a protein down-regulated by Gal-3. Moreover, Gal-3 induced a decrease in total antioxidant capacity which resulted in a consequent increase in peroxide levels and oxidative stress markers in cardiac fibroblasts.’ We would like to point out some results stated in the article that need further investigation and more detailed discussion to clarify certain factors involved in the protective role of Prx-4 in heart failure.


Sign in / Sign up

Export Citation Format

Share Document